Join
Live feed
·
INSIDERFilingvia Quantisnow
Apogee Therapeutics Inc. logo

Chief Executive Officer Henderson Michael Thomas sold $1,641,711 worth of shares (20,000 units at $82.09) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,115,987 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APGE· Apogee Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APGE (Apogee Therapeutics Inc.) and more on Quantisnow.